Liver News and Research

RSS

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026

Major studies identify accurate non-invasive tests for liver disease

Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.

29 Oct 2026

Multivitamins boost key vitamin levels, but do they improve your health?

A scoping review of 157 clinical trial reports found that multivitamins consistently improved circulating levels of folate, vitamin B6, and vitamin B12, while other nutritional and clinical effects varied by formulation, population, and baseline nutritional status. Selected prenatal and cognitive outcomes improved in some trials, but evidence for cardiovascular disease prevention was largely negative, and the review could not establish the overall certainty of clinical benefits.

29 Oct 2026

AI tool reads abdominal ultrasounds and accelerates emergency diagnoses

When a patient arrives in the emergency department with severe abdominal pain, every minute counts. Researchers at the University of Colorado Anschutz School of Medicine are investigating ways to streamline the work of radiologists and make it more efficient.

29 Oct 2026

Can broccoli sprouts help with insulin resistance? New review offers clues

A review published in the British Journal of Nutrition examines how carotenoids and bioactive compounds in Brassicaceae microgreens may influence obesity, insulin resistance, and type 2 diabetes through metabolic and inflammatory pathways. Small human trials involving broccoli sprouts have reported improvements in selected metabolic markers, but larger, longer-term studies are needed to establish their clinical benefits.

29 Oct 2026

Fish, shellfish or seaweed? A Korean study found striking differences in chemical exposure

A national study of 4,279 Korean adults found that higher finfish consumption was associated with increased blood concentrations of PFAS, PCBs, and mercury, while shellfish showed narrower associations with three PFAS. Persistent chemical mixtures were also associated with modest increases in liver health biomarkers, and mediation analysis identified a positive PFAS-related pathway, although finfish intake was not significantly associated with GGT overall.

29 Oct 2026

Soft robotic enteroscope offers a new approach to small intestine examination

An innovative robotic device inspired by snake movement could someday help gastroenterologists diagnose and treat inflammatory bowel disease (IBD) and other disorders of the small intestine and remove small polyps while reducing trauma to the organ's delicate tissues.

28 Oct 2026

Targeted drug combination extends survival in advanced kidney cancer

Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both progression-free and overall survival in patients with the most common type of kidney cancer.

28 Oct 2026

Study identifies common mechanism behind widespread cancer mutations

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.

28 Oct 2026

New research center aims to accelerate hepatitis C vaccine development

The shifty hepatitis C virus (HCV) has a knack for outmaneuvering the immune system. Its secret is an especially high mutation rate, which has generated an abundance of viral variants with extreme genetic diversity.

27 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Plasma proteins offer clues to biological aging and mortality risk

A new study published in Geromedicine has identified 17 plasma proteins associated with all-cause mortality in older adults and found that several of these proteins also track with measures of biological aging across multiple organ systems.

27 Oct 2026

Endometrial cancer rates rise sharply among younger South Texas women

An Upper-South region of Texas including San Antonio and Bexar County had the state's highest hysterectomy-corrected incidence of endometrial cancer and the largest increase over time, a study led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute showed.

27 Oct 2026

Machine learning models predict common cancer risks using routine health data

Machine learning models using routinely collected health information, such as blood tests, medical history and lifestyle factors, could help identify people at higher risk of several common cancers, according to an international study reported at the ESMO Congress 2026.

27 Oct 2026

Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more than tripled progression-free survival, and reduced the risk of death by 58% compared to durvalumab alone, according to results of the phase 3 open-label, multicenter, randomized DeLLphi-305 study, which was presented by Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, during the Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain, on Oct. 24.

26 Oct 2026

New augmented reality technology guides surgeons to hidden tumors

A research collaboration in Gothenburg has developed technology that creates an interactive 3D image of an organ during surgery.

26 Oct 2026

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Beer, wine or spirits: A large study finds different mortality patterns for each

Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.

25 Oct 2026

Kidney Week 2026 features late-breaking clinical trials in kidney care

The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25.

24 Oct 2026

PFAS levels in United States drinking water may be underestimated

Common ways of reporting perfluoroalkyl and polyfluoroalkyl substances (PFAS)-the man-made, so-called forever chemicals that pose environmental and health threats-could underestimate the concentration of PFAS in United States drinking water by as much as half, finds a study publishing October 23 in the Cell Press journal Cell Reports Sustainability.

24 Oct 2026